ATE365703T1 - Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen - Google Patents
Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungenInfo
- Publication number
- ATE365703T1 ATE365703T1 AT03762749T AT03762749T ATE365703T1 AT E365703 T1 ATE365703 T1 AT E365703T1 AT 03762749 T AT03762749 T AT 03762749T AT 03762749 T AT03762749 T AT 03762749T AT E365703 T1 ATE365703 T1 AT E365703T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- diphenylprop
- substituted
- applications
- preparation
- Prior art date
Links
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical class C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 title abstract 2
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0208571A FR2841900B1 (fr) | 2002-07-08 | 2002-07-08 | Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE365703T1 true ATE365703T1 (de) | 2007-07-15 |
Family
ID=29725283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03762749T ATE365703T1 (de) | 2002-07-08 | 2003-07-08 | Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen |
Country Status (24)
Country | Link |
---|---|
US (3) | US7943661B2 (de) |
EP (1) | EP1525177B1 (de) |
JP (1) | JP4575771B2 (de) |
KR (1) | KR100974577B1 (de) |
CN (1) | CN100548960C (de) |
AT (1) | ATE365703T1 (de) |
AU (1) | AU2003264698B2 (de) |
BR (1) | BRPI0312398B8 (de) |
CA (1) | CA2490986C (de) |
CY (1) | CY1108085T1 (de) |
DE (1) | DE60314633T2 (de) |
DK (1) | DK1525177T3 (de) |
EA (1) | EA011090B1 (de) |
ES (1) | ES2287528T3 (de) |
FR (1) | FR2841900B1 (de) |
IL (2) | IL165696A0 (de) |
MX (1) | MXPA05000427A (de) |
NO (1) | NO329700B1 (de) |
NZ (1) | NZ538051A (de) |
PL (1) | PL207362B1 (de) |
PT (1) | PT1525177E (de) |
SI (1) | SI1525177T1 (de) |
WO (1) | WO2004005233A1 (de) |
ZA (1) | ZA200501082B (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2841900B1 (fr) | 2002-07-08 | 2007-03-02 | Genfit S A | Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations |
FR2841784B1 (fr) | 2002-07-08 | 2007-03-02 | Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations | |
AU2005209446A1 (en) * | 2004-01-08 | 2005-08-11 | Genfit | 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same |
FR2902789A1 (fr) | 2006-06-21 | 2007-12-28 | Genfit Sa | Derives de 1,3-diphenylpropane substitues, preparations et utilisations |
US20100285126A1 (en) * | 2007-08-02 | 2010-11-11 | Rahul Dabre | Pharmaceutical compositions of fenofibrate |
CN102647982B (zh) | 2009-11-26 | 2014-10-15 | 基恩菲特公司 | 使用1,3-二苯基丙-2-烯-1-酮衍生物治疗肝脏疾患 |
US10722575B2 (en) | 2009-11-26 | 2020-07-28 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
US9221751B2 (en) | 2009-11-26 | 2015-12-29 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
WO2011080276A1 (en) | 2009-12-29 | 2011-07-07 | Genfit | Pharmaceutical combinations comprising a dpp-4 inhibitor and a 1,3-diphenylprop-2-en-1-one derivative |
HUE035810T2 (en) | 2010-05-17 | 2018-05-28 | Genfit | An improved method for producing chalcone derivatives |
TWI415600B (zh) * | 2011-08-10 | 2013-11-21 | Univ Kaohsiung Medical | 用於治療動脈粥狀硬化的組合物及其製備方法 |
CN104185471B (zh) | 2011-12-28 | 2018-03-30 | 基恩菲特公司 | 1,3‑二苯基丙烷衍生物、其制备以及用途 |
CN102697757B (zh) * | 2012-05-18 | 2014-06-04 | ***广州总医院 | 对羟基苄叉丙酮在制备预防和/或治疗脑病药物中的应用 |
EP2948137B1 (de) * | 2013-01-18 | 2018-11-14 | Genfit | Verfahren zur behandlung von fibrose und krebs |
EP3416629A4 (de) | 2016-02-16 | 2019-08-07 | CoNCERT Pharmaceuticals, Inc. | Deuteriertes gft-505 |
CN114796237B (zh) | 2016-03-31 | 2024-02-23 | 基恩菲特公司 | 胆汁淤积性疾病的治疗方法 |
FR3056908B1 (fr) | 2016-09-30 | 2019-04-19 | Nashpharm | Sel de metformine et d'elafibranor presentant une activite duale pour le traitement de l'obesite associee a la steato-hepatite non alcoolique (nash) et a l'hypertriglyceridemie |
FR3056909B1 (fr) | 2016-09-30 | 2019-04-19 | Nashpharm | Composition comprenant au moins un sel pharmaceutiquement acceptable d'elafibranor soluble en milieux aqueux presentant une absorption intestinale amelioree |
WO2018112037A1 (en) * | 2016-12-16 | 2018-06-21 | Jia Zhou | Inhibitors of bromodomain-containing protein 4 (brd4) |
CA3051146A1 (en) * | 2017-01-22 | 2018-07-26 | Crystal Pharmaceutical (Suzhou) Co., Ltd. | Crystal form of gft-505 and preparation method and use thereof |
WO2018153933A1 (en) | 2017-02-21 | 2018-08-30 | Genfit | Combination of a ppar agonist with a fxr agonist |
US11590108B2 (en) | 2017-02-24 | 2023-02-28 | Genfit | Pharmaceutical compositions for combination therapy |
MX2019012534A (es) | 2017-04-18 | 2020-08-17 | Genfit | Combinacion de elafibranor o derivados del mismo con un agente anti-ehna, antifibrotico o anticolestasico. |
CN108658908B (zh) * | 2017-07-31 | 2019-05-10 | 广州必贝特医药技术有限公司 | 1,3-二取代烯酮类化合物及其应用 |
CA3071202A1 (en) | 2017-08-04 | 2019-02-07 | Advitech Advisory And Technologies Sa | Process for the preparation of elafibranor and novel synthesis intermediates |
US20200276178A1 (en) | 2017-09-13 | 2020-09-03 | Novartis Ag | Combinations comprising fxr agonists |
EP3710425A1 (de) | 2017-11-16 | 2020-09-23 | Teva Pharmaceuticals International GmbH | Festkörperformen von elafibranor |
US11332457B2 (en) | 2017-11-30 | 2022-05-17 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Aromatic compound, pharmaceutical composition and use thereof |
EP3514541A1 (de) | 2018-01-17 | 2019-07-24 | Siemens Healthcare Diagnostics Products GmbH | Verfahren zur quantitativen bestimmung eines therapeutischen tnf-alpha inhibitors |
WO2019186410A1 (en) * | 2018-03-27 | 2019-10-03 | Lupin Limited | Solid forms of elafibranor and processes thereof |
TW202019870A (zh) | 2018-08-03 | 2020-06-01 | 法商Genfit公司 | 艾拉菲諾鹽 |
WO2020039297A1 (en) * | 2018-08-24 | 2020-02-27 | Mankind Pharma Ltd. | Novel compounds and their use in preparation of elafibranor and pharmaceutical acceptable salts thereof |
WO2020115628A1 (en) * | 2018-12-03 | 2020-06-11 | Mankind Pharma Ltd. | Solid forms of elafibranor and process of preparation thereof |
CN110156648A (zh) * | 2019-05-30 | 2019-08-23 | 河北科技大学 | 一种Elafibranor中间体的制备方法 |
EP4051257A1 (de) | 2019-10-28 | 2022-09-07 | Genfit | Kombinationstherapie mit antioxidanseigenschaften |
CN112824380A (zh) * | 2019-11-21 | 2021-05-21 | 杭州百诚医药科技股份有限公司 | α-氟代查耳酮类衍生物及其应用 |
CN111138264B (zh) * | 2019-11-29 | 2023-08-04 | 温州医科大学 | 一种丁香醛衍生物及其在制备抗妇科肿瘤药物中的应用 |
CN113121394B (zh) * | 2019-12-30 | 2022-11-08 | 中国药科大学 | 一种苯氧乙酸类衍生物的制备方法 |
CA3163583A1 (en) | 2020-02-10 | 2021-08-19 | Genfit | Polymorphs of elafibranor |
AU2021275381A1 (en) | 2020-05-18 | 2022-11-24 | Genfit | Elafibranor for the treatment of primary sclerosing cholangitis |
MX2023002159A (es) | 2020-08-26 | 2023-03-01 | Genfit | Composiciones y metodos para el tratamiento de la colangitis biliar primaria. |
CN113230240B (zh) * | 2021-03-22 | 2022-12-27 | 广州医科大学 | 1,3-二苯基丙-2-烯-1-酮衍生物及其应用 |
CN114853686B (zh) | 2021-08-23 | 2023-06-20 | 中国药科大学 | 三氮唑酮类化合物及其医药用途 |
CN115894379A (zh) | 2022-01-20 | 2023-04-04 | 中国药科大学 | 海因类化合物及其医药用途 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558612A (en) | 1968-05-22 | 1971-01-26 | Dow Chemical Co | Substituted phenoxyacetic acids |
CH593224A5 (de) * | 1973-10-30 | 1977-11-30 | Taisho Pharmaceutical Co Ltd | |
US3994955A (en) * | 1975-01-20 | 1976-11-30 | G. D. Searle & Co. | Substituted phenoxydialkylacetic acids and esters |
JPS5278856A (en) | 1975-12-26 | 1977-07-02 | Taisho Pharmaceut Co Ltd | Preparation of chalcone ethers |
US4190671A (en) | 1977-03-17 | 1980-02-26 | Biorex Laboratories Limited | Chalcone derivatives |
JPS5419947A (en) | 1977-07-16 | 1979-02-15 | Taisho Pharmaceut Co Ltd | Chalcone derivatives |
GB8426424D0 (en) * | 1984-10-19 | 1984-11-28 | Biorex Laboratories Ltd | Chalcone derivatives |
JPS6310720A (ja) | 1986-07-01 | 1988-01-18 | Nippon Kayaku Co Ltd | 5−リポキシゲナ−ゼ阻害剤および抗アレルギ−剤 |
JPH023670A (ja) | 1988-06-22 | 1990-01-09 | Nippon Oil & Fats Co Ltd | アルキルチオカルコン誘導体 |
US5109025A (en) | 1988-11-25 | 1992-04-28 | Dainippon Ink And Chemicals, Inc. | Therapeutic agent for penal disorders |
JPH0442229A (ja) * | 1990-06-08 | 1992-02-12 | Fujitsu Ltd | レジスト材料およびパターンの形成方法 |
JPH05255655A (ja) | 1992-03-12 | 1993-10-05 | Kanebo Ltd | 紫外線吸収剤 |
JPH06122623A (ja) | 1992-10-09 | 1994-05-06 | Minofuaagen Seiyaku Honpo:Goushi | 抗腫瘍剤 |
US5276058A (en) * | 1993-06-09 | 1994-01-04 | Nippon Hypox Laboratories Incorporated | 3,4-dihydroxychalcone derivatives |
DE4327365A1 (de) * | 1993-08-14 | 1995-02-16 | Boehringer Mannheim Gmbh | Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung |
US5523302A (en) | 1993-11-24 | 1996-06-04 | The Du Pont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
AU5474198A (en) * | 1996-12-24 | 1998-07-17 | National Research Council Of Canada | Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals |
EP0947511A1 (de) | 1998-03-30 | 1999-10-06 | F. Hoffmann-La Roche Ag | Phenoxy-Essigsäurederivate und Phenoxymetyl-Tetrazolderivate mit antitumoraler Wirkung |
CN1327384A (zh) | 1998-10-20 | 2001-12-19 | 韩国科学技术研究院 | 作为血浆高密度脂蛋白浓度增高剂的生物类黄酮 |
JP4249926B2 (ja) * | 2000-01-27 | 2009-04-08 | タカラバイオ株式会社 | 治療剤 |
EP1330448A2 (de) | 2000-06-20 | 2003-07-30 | Atherogenics, Inc. | 1,3-bis-(substituiertes phenyl)-2-propen-1-one und ihre verwendung bei der behandlung vcam-1-vermittelter erkrankungen |
EP1254759B1 (de) | 2001-05-03 | 2009-03-18 | Leister Process Technologies | Düse zum Schweissen von Kunststoffbahnen oder -folien |
FR2841784B1 (fr) * | 2002-07-08 | 2007-03-02 | Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations | |
FR2841900B1 (fr) | 2002-07-08 | 2007-03-02 | Genfit S A | Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations |
FR2857361B1 (fr) | 2003-07-08 | 2005-09-09 | Genfit S A | PREPARATION DE DERIVES DE 1,3-DIPHENYPROP-2-¼n-1-one |
AU2005209446A1 (en) * | 2004-01-08 | 2005-08-11 | Genfit | 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same |
-
2002
- 2002-07-08 FR FR0208571A patent/FR2841900B1/fr not_active Expired - Fee Related
-
2003
- 2003-07-08 DK DK03762749T patent/DK1525177T3/da active
- 2003-07-08 IL IL16569603A patent/IL165696A0/xx unknown
- 2003-07-08 MX MXPA05000427A patent/MXPA05000427A/es active IP Right Grant
- 2003-07-08 EP EP03762749A patent/EP1525177B1/de not_active Expired - Lifetime
- 2003-07-08 CA CA2490986A patent/CA2490986C/fr not_active Expired - Fee Related
- 2003-07-08 JP JP2004518890A patent/JP4575771B2/ja not_active Expired - Lifetime
- 2003-07-08 ES ES03762749T patent/ES2287528T3/es not_active Expired - Lifetime
- 2003-07-08 WO PCT/FR2003/002127 patent/WO2004005233A1/fr active IP Right Grant
- 2003-07-08 US US10/520,079 patent/US7943661B2/en active Active
- 2003-07-08 BR BRPI0312398A patent/BRPI0312398B8/pt not_active IP Right Cessation
- 2003-07-08 AU AU2003264698A patent/AU2003264698B2/en not_active Ceased
- 2003-07-08 AT AT03762749T patent/ATE365703T1/de active
- 2003-07-08 NZ NZ538051A patent/NZ538051A/en not_active IP Right Cessation
- 2003-07-08 CN CNB038163667A patent/CN100548960C/zh not_active Expired - Lifetime
- 2003-07-08 PT PT03762749T patent/PT1525177E/pt unknown
- 2003-07-08 KR KR1020057000349A patent/KR100974577B1/ko active IP Right Grant
- 2003-07-08 PL PL372809A patent/PL207362B1/pl unknown
- 2003-07-08 SI SI200330864T patent/SI1525177T1/sl unknown
- 2003-07-08 EA EA200500169A patent/EA011090B1/ru not_active IP Right Cessation
- 2003-07-08 DE DE60314633T patent/DE60314633T2/de not_active Expired - Lifetime
-
2004
- 2004-12-03 NO NO20045301A patent/NO329700B1/no not_active IP Right Cessation
- 2004-12-09 IL IL165696A patent/IL165696A/en active IP Right Grant
-
2005
- 2005-02-07 ZA ZA200501082A patent/ZA200501082B/xx unknown
-
2006
- 2006-07-26 US US11/493,040 patent/US7566737B2/en not_active Expired - Lifetime
-
2007
- 2007-08-03 CY CY20071101040T patent/CY1108085T1/el unknown
-
2011
- 2011-04-11 US US13/083,659 patent/US8058308B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60314633D1 (de) | Substituierte 1,3-diphenylprop-2-en-1-on derivate, deren herstellung und anwendungen | |
EP1399414A4 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
ATE478840T1 (de) | 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung | |
IL216579A (en) | History of aminocyclohexyl ether and pharmacy preparations containing them | |
ECSP045081A (es) | Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados | |
SG162773A1 (en) | Flavonoid compounds and uses thereof | |
PT1313489E (pt) | Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet | |
WO2004060882A8 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
DE69725825D1 (de) | 5-HT1F-Agonisten | |
WO2002076402A3 (en) | Fatty amine drug conjugates | |
TR200200821T2 (tr) | 5-Beta-sapojenin ve pseudosapojenin türevleri ve bunların bunama tedavisinde kullanımı. | |
ATE369355T1 (de) | Pyrimidinamid derivate und deren verwendung | |
BR0201862A (pt) | Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos | |
ATE479657T1 (de) | N-(aryl)-2-arylethensulfonamide und ihre therapeutischen anwendungen | |
ATE267816T1 (de) | Tan-1057 derivate | |
AU2002368133A1 (en) | 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis | |
BR0309996A (pt) | Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias | |
SE0300457D0 (sv) | Novel compounds | |
NO20002408D0 (no) | 5-HT1F antagonister | |
MXPA03010259A (es) | Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. | |
DE60003074D1 (de) | Fusidinsäure-derivate | |
DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
BRPI0410638A (pt) | derivados de azitromicina | |
CY1106552T1 (el) | Ενωσεις ισοχρωμανιου για την θεραπεια ανωμαλιων του κνς | |
ATE293107T1 (de) | Luminacine analoge und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1525177 Country of ref document: EP |